DAN DAN 5335
Pill imprint DAN DAN 5335 has been identified as Trihexyphenidyl hydrochloride 2 mg.
Trihexyphenidyl is used in the treatment of parkinson's disease; cerebral spasticity; extrapyramidal reaction and belongs to the drug class anticholinergic antiparkinson agents. FDA has not classified the drug for risk during pregnancy.
Trihexyphenidyl 2 mg is not subject to the Controlled Substances Act.
See also related documents.
Trihexyphenidyl hydrochloride Images
- Imprint:
-
DAN DAN
5335 - Strength:
- 2 mg
- Color:
- White
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
dibasic calcium phosphate
lactose monohydrate
magnesium stearate
microcrystalline cellulose
sodium starch glycolate
- Drug Class:
- Anticholinergic antiparkinson agents
- Pregnancy Category:
- N - Not yet classified
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Laboratories, Inc.
- National Drug Code (NDC):
- 00591-5335
Advertisement
More Trihexyphenidyl Hydrochloride resources
- Trihexyphenidyl (Wolters Kluwer)
- Trihexyphenidyl Elixir (Wolters Kluwer)
- trihexyphenidyl (Cerner Multum)
- Tritane (Micromedex) - Includes Dosage Information
- trihexyphenidyl (Micromedex) - Includes Dosage Information
- Trihexyphenidyl Hydrochloride (AHFS DI)
- Trihexyphenidyl (FDA)
- Trihexyphenidyl Elixir (FDA)
- Trihexyphenidyl Oral Solution (FDA)
- Trihexyphenidyl Hydrochloride (Wolters Kluwer)
Search Again
